Abstract
Objectives: The mucosa of human detrusor strips impairs catecholamine-induced relaxation. In order to elucidate which signal transduction pathways are involved in this cross talk between the mucosa and detrusor, we have studied the effects of several pharmacological agonists and antagonists on noradrenaline-mediated relaxation in intact and mucosa-denuded detrusor strips. Patients and Methods: Strips of detrusor tissue were obtained from patients who had undergone cystectomy for bladder cancer and were set up for force measurement. KCl- or carbachol-precontracted strips were relaxed with increasing concentrations of noradrenaline in the absence and in the presence of nitric oxide synthase inhibitor, L-NAME; P2X-receptor antagonist, PPADS; ETA-receptor antagonist, BQ-123; ETB-receptor antagonist, BQ-788; cyclooxygenase inhibitor, diclofenac; AT1-receptor antagonist, candesartan; and NK1-receptor antagonist, L-703,606. Results: In intact strips, KCl-stimulated force was enhanced by all blockers; carbachol-stimulated force increased with L-703,606. In denuded strips, only L-NAME augmented the KCl-stimulated contraction. Noradrenaline relaxed the precontracted detrusor strips to a significantly larger extent and at lower concentrations in denuded than in intact strips. L-NAME, PPADS and BQ-123/BQ-788 had little effect on noradrenaline-induced relaxation, whereas diclofenac, candesartan and L-703,606 sensitized intact carbachol-stimulated detrusor strips to noradrenaline-induced relaxation. Conclusion: Inhibition of the noradrenaline-induced relaxation of precontracted human detrusor strips by the mucosa is attenuated by diclofenac, candesartan and L-703,606 suggesting the involvement of prostanoids, angiotensin and neurokinin pathways. Further experiments are required to unravel the exact mechanisms.
Journal Section:
Editor's choice
References
1.
Kosilov KV, Loparev SA, Ivanovskaya MA, Kosilova LV: Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women. Urol Int 2014;93:470-473.
[PubMed]
2.
Chapple C, Khullar V, Nitti VW, Frankel J, Herschorn S, Kaper M, Blauwet MB, Siddiqui E: Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol 2015;67:11-14.
[PubMed]
3.
Andersson KE, Arner A: Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 2004;84:935-986.
[PubMed]
4.
Hawthorn MH, Chapple CR, Cock M, Chess-Williams R: Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 2000;129:416-419.
[PubMed]
5.
Masunaga K, Chapple CR, McKay NG, Yoshida M, Sellers DJ: The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome. Neurourol Urodyn 2010;29:1320-1325.
[PubMed]
6.
Propping S, Wuest M, Eichhorn B, Wirth MP, Kaumann AJ, Ravens U: Mucosa of human detrusor impairs contraction and β-adrenoceptor-mediated relaxation. BJU Int 2013;112:1215-1222.
[PubMed]
7.
Wuest M, Kaden S, Hakenberg OW, Wirth MP, Ravens U: Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium. Naunyn Schmiedebergs Arch Pharmacol 2005;372:203-212.
[PubMed]
8.
Maggi CA, Santicioli P, Parlani M, Astolfi M, Patacchini R, Meli A: The presence of mucosa reduces the contractile response of the guinea-pig urinary bladder to substance P. J Pharm Pharmacol 1987;39:653-655.
[PubMed]
9.
Chaiyaprasithi B, Mang CF, Kilbinger H, Hohenfellner M: Inhibition of human detrusor contraction by a urothelium derived factor. J Urol 2003;170:1897-1900.
[PubMed]
10.
Levin RM, Wein AJ, Krasnopolsky L, Atta MA, Ghoniem GM: Effect of mucosal removal on the response of the feline bladder to pharmacological stimulation. J Urol 1995;153:1291-1294.
[PubMed]
11.
Morita T, Iizuka H, Iwata T, Kondo S: Function and distribution of beta3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter. J Smooth Muscle Res 2000;36:21-32.
[PubMed]
12.
Yamanishi T, Chapple CR, Yasuda K, Yoshida K, Chess-Williams R: The role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscle. Br J Pharmacol 2002;135:129-134.
[PubMed]
13.
Murakami S, Chapple CR, Akino H, Sellers DJ, Chess-Williams R: The role of the urothelium in mediating bladder responses to isoprenaline. BJU Int 2007;99:669-673.
[PubMed]
14.
Otsuka A, Shinbo H, Matsumoto R, Kurita Y, Ozono S: Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium. Naunyn Schmiedebergs Arch Pharmacol 2008;377:473-481.
[PubMed]
15.
Wuest M, Eichhorn B, Grimm MO, Wirth MP, Ravens U, Kaumann AJ: Catecholamines relax detrusor through beta 2-adrenoceptors in mouse and beta 3-adrenoceptors in man. J Pharmacol Exp Ther 2009;328:213-222.
[PubMed]
16.
Propping S, Newe M, Lorenz K, Wirth MP, Ravens U: β-Adrenoceptor-mediated relaxation of carbachol-pre-contracted mouse detrusor. Urol Int 2015, Epub ahead of print.
[PubMed]
17.
Yoshida M, Masunaga K, Satoji Y, Maeda Y, Nagata T, Inadome A: Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in urothelium and its clinical significance. J Pharmacol Sci 2008;106:193-198.
[PubMed]
18.
Ferguson DR, Kennedy I, Burton TJ: ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - a possible sensory mechanism? J Physiol 1997;505:503-511.
[PubMed]
19.
Lecci A, Maggi CA: Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept 2001;101:1-18.
[PubMed]
20.
Khan MA, Thompson CS, Mumtaz FH, Jeremy JY, Morgan RJ, Mikhailidis DP: Role of prostaglandins in the urinary bladder: an update. Prostaglandins Leukot Essent Fatty Acids 1998;59:415-422.
[PubMed]
21.
Arrighi N, Bodei S, Lucente A, Michel MC, Zani D, Simeone C, Cunico SC, Spano P, Sigala S: Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa. Pharmacol Res 2011;64:420-425.
[PubMed]
22.
Ochodnický P, Humphreys S, Eccles R, Poljakovic M, Wiklund P, Michel MC: Expression profiling of g-protein-coupled receptors in human urothelium and related cell lines. BJU Int 2012;110:E293-E300.
[PubMed]
23.
Moro C, Chess-Williams R: Non-adrenergic, non-cholinergic, non-purinergic contractions of the urothelium/lamina propria of the pig bladder. Auton Autacoid Pharmacol 2012;32:53-59.
[PubMed]
24.
Sui GP, Wu C, Fry CH: A description of ca2+ channels in human detrusor smooth muscle. BJU Int 2003;92:476-482.
[PubMed]
25.
Guan NN, Thor A, Hallén K, Wiklund NP, Gustafsson LE: Cascade bioassay evidence for the existence of urothelium-derived inhibitory factor in guinea pig urinary bladder. PLoS One 2014;9:e103932.
[PubMed]
26.
Guan NN, Nilsson KF, Wiklund PN, Gustafsson LE: Release and inhibitory effects of prostaglandin D2 in guinea pig urinary bladder and the role of urothelium. Biochim Biophys Acta 2014;1840:3443-3451.
[PubMed]
27.
Jeremy JY, Dandona P: Fluoride but not phorbol esters stimulate rat urinary bladder prostanoid synthesis: investigations into the roles of G proteins and protein kinase C. Prostaglandins Leukot Med 1987;29:129-139.
[PubMed]
28.
Anderson KE: Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev 1993;45:253-308.
[PubMed]
29.
Rahnama'i MS, van Kerrebroeck PE, de Wachter SG, van Koeveringe GA: The role of prostanoids in urinary bladder physiology. Nat Rev Urol 2012;9:283-290.
[PubMed]
30.
Comiter C, Phull HS: Angiotensin II type 1 (AT-1) receptor inhibition partially prevents the urodynamic and detrusor changes associated with bladder outlet obstruction: a mouse model. BJU Int 2012;109:1841-1846.
[PubMed]
31.
Phull H, Salkini M, Escobar C, Purves T, Comiter CV: The role of angiotensin II in stress urinary incontinence: a rat model. Neurourol Urodyn 2007;26:81-88; discussion 89.
[PubMed]
32.
Ito H, Taga M, Tsuchiyama K, Akino H, Yokoyama O: IPSS is lower in hypertensive patients treated with angiotensin-II receptor blocker: posthoc analyses of a lower urinary tract symptoms population. Neurourol Urodyn 2013;32:70-74.
[PubMed]
33.
Nomiya M, Yamaguchi O: A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 2003;170:649-653.
[PubMed]
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.
